⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIIB News
Biogen Inc. Common Stock
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
globenewswire.com
BIIB
Biointron Launches RushData, an Integrated High-Throughput Platform for AI-Driven Antibody Discovery
globenewswire.com
BIIB
NVIDIA Announces BioNeMo Agent Toolkit — Tools for Agents to Accelerate Scientific Discovery
globenewswire.com
NVDA
LRCX
AMAT
SNOW
CDNS
MRVL
MU
SMCI
AMD
INTC
QCOM
GOOG
MSFT
AMZN
LLY
NTRS
REGN
GILD
BMY
PFE
MRNA
BIIB
VRTX
CRSP
EXAS
ROST
DSY
TMO
Questex’s PODD, the Premier Gathering for Drug Delivery Industry Leaders, Announces the 16th Annual Conference Agenda
globenewswire.com
ABBV
ALNY
ASTL
AZN
BIIB
BMY
CSL
LLY
GILD
GSK
MRK
NVS
NVO
PFE
REGN
SNY
SUN
TEVA
UPST
VRTX
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biogen Inc. - BIIB
accessnewswire.com
BIIB
Cutaneous Lupus Erythematosus Market to Expand at a CAGR of 8% During the Forecast Period (2026–2036) Amid Emerging Therapies and Increasing Healthcare Investments | DelveInsight
globenewswire.com
BIIB
AMGN
BMY
IMVT
AZN
MRK
CTNT
REGN
GILD
International Regulatory Pathways Have Supported Drug Development Across Biotech and Pharma
globenewswire.com
NTHI
LLY
BIIB
BBIO
Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
globenewswire.com
QNTM
SNY
BIIB
CLNN
Oxford BioTherapeutics' Third Partnered Programme with Boehringer Ingelheim Enters the Clinic and its First (Obrixtamig) Advances to Phase 3
globenewswire.com
BIIB
GSK
Bronstein, Gewirtz & Grossman, LLC Is Investigating Biogen Inc. (BIIB) And Encourages Shareholders to Connect
accessnewswire.com
BIIB